Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price Target
Original Source
Read the full article at Finance →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.